Insight Into Novel Anti-tuberculosis Vaccines by Using Immunoinformatics Approaches. [PDF]
Front Microbiol, 2022 Khan Z +5 more
europepmc +1 more source
New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01<sub>E</sub> and BCG-revaccination. [PDF]
BMC Med, 2023 Clark RA +12 more
europepmc +1 more source
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development. [PDF]
Front Immunol, 2022 Hu Z, Lu SH, Lowrie DB, Fan XY.
europepmc +1 more source
Key Issues in Vaccine-Based Tuberculosis Prevention for Children within Family Medicine Systems in Ukraine [PDF]
, 2022 A. М. Krychkovska +3 more
openalex +1 more source
A febrile papulovesicular rash in a patient with pyoderma gangrenosum
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 237-239, February 2026.
Anika Rajput Khokhar +5 more
wiley +1 more source
Evaluation of Immunogenicity of Mycobacterium tuberculosis ag85ab DNA Vaccine Delivered by Pulmonary Administration [PDF]
Haimei Zhao +11 more
openalex +1 more source
Paving the way to a new class of efficient and safe tuberculosis vaccines: The role of c-di-AMP in Mycobacterium tuberculosis immunity and virulence. [PDF]
Mol Ther Nucleic Acids, 2022 El Zowalaty ME, Ashour HM.
europepmc +1 more source
Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021. [PDF]
Vaccine, 2021 Suliman S +4 more
europepmc +1 more source
Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations
, 2008 Willem A. Hanekom +9 more
openalex +2 more sources